2024-04-01 2025-03-31 false Capium Accounts Production 1.1 07008993 2024-04-01 2025-03-31 07008993 bus:AbridgedAccounts 2024-04-01 2025-03-31 07008993 bus:FRS102 2024-04-01 2025-03-31 07008993 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 07008993 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 07008993 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 07008993 2024-04-01 2025-03-31 07008993 2025-03-31 07008993 bus:RegisteredOffice 2024-04-01 2025-03-31 07008993 core:WithinOneYear 2025-03-31 07008993 core:AfterOneYear 2025-03-31 07008993 1 2024-04-01 2025-03-31 07008993 bus:Director1 2024-04-01 2025-03-31 07008993 bus:Director1 2025-03-31 07008993 bus:Director1 2023-04-01 2024-03-31 07008993 bus:Director2 2024-04-01 2025-03-31 07008993 bus:Director2 2025-03-31 07008993 bus:Director2 2023-04-01 2024-03-31 07008993 2023-04-01 07008993 bus:LeadAgentIfApplicable 2024-04-01 2025-03-31 07008993 2023-04-01 2024-03-31 07008993 2024-03-31 07008993 core:WithinOneYear 2024-03-31 07008993 core:AfterOneYear 2024-03-31 07008993 bus:EntityAccountantsOrAuditors 2023-04-01 2024-03-31 07008993 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 07008993 bus:OrdinaryShareClass1 2025-03-31 07008993 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 07008993 bus:OrdinaryShareClass1 2024-03-31 07008993 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 07008993 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 07008993 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-03-31 07008993 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 07008993 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 07008993 core:Non-currentFinancialInstruments 2025-03-31 07008993 core:Non-currentFinancialInstruments 2024-03-31 07008993 core:ShareCapital 2025-03-31 07008993 core:ShareCapital 2024-03-31 07008993 core:RetainedEarningsAccumulatedLosses 2025-03-31 07008993 core:RetainedEarningsAccumulatedLosses 2024-03-31 07008993 dpl:Item1 2024-04-01 07008993 dpl:Item1 2025-03-31 07008993 dpl:Item1 2023-04-01 07008993 dpl:Item1 2024-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 07008993
England and Wales

 

 

 

SIMONELISH MEDICAL LIMITED



Abridged Accounts
 


Period of accounts

Start date: 01 April 2024

End date: 31 March 2025

SIMONELISH MEDICAL LIMITED
Contents Page
For the year ended 31 March 2025
Report to the directors on the preparation of the unaudited statutory accounts of SIMONELISH MEDICAL LIMITED year ended 31 March 2025
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of SIMONELISH MEDICAL LIMITED for the year ended 31 March 2025 which comprise the Profit and Loss Account, the Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.
This report is made solely to the Directors of SIMONELISH MEDICAL LIMITED, as a body, in accordance with the terms of our engagement. Our work has been undertaken solely to prepare for your approval the accounts of SIMONELISH MEDICAL LIMITED
To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than SIMONELISH MEDICAL LIMITED and its Directors as a body for our work or for this report.
It is your duty to ensure that SIMONELISH MEDICAL LIMITED has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and Profit of SIMONELISH MEDICAL LIMITED.
You consider that SIMONELISH MEDICAL LIMITED is exempt from the statutory audit requirement for the year ended 31 March 2025. We have not been instructed to carry out an audit or a review of the accounts of SIMONELISH MEDICAL LIMITED. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.




....................................................
LIGHTHALL CONSULT
UNIT 128 FIRST FLOOR
415 HIGH STREET
STRATFORD, LONDON
E15 4QZ
15 August 2025
1
 
 		 Notes
 		 2025
£		   2024
£
Current assets      
Debtors: amounts falling due within one year 6,928    10,881 
Cash at bank and in hand 987    1,004 
7,915    11,885 
Creditors: amount falling due within one year (4,460)   (3,141)
Net current assets 3,455    8,744 
 
Total assets less current liabilities 3,455    8,744 
Creditors: amount falling due after more than one year (13,004)   (21,604)
Net assets (9,549)   (12,860)
 

Capital and reserves 		     
Called up share capital 3 1,000    1,000 
Profit and loss account (10,549)   (13,860)
Shareholders' funds (9,549)   (12,860)
 


For the year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the board of directors on 15 August 2025 and were signed on its behalf by:


-------------------------------
Samuel Oluwafemi AKINBOBOYE
Director
2
General Information
SIMONELISH MEDICAL LIMITED is a private company, limited by shares, registered in England and Wales, registration number 07008993, registration address 108, LANES AVENUE, NORTHFLEET GRAVESEND, Northfleet, Kent, DA11 7HS.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Cost of sales
The cost of sales figure represents the costs that are incurred as a direct result of providing the services which form the core of the services provided by the company
Taxation
Taxation was provided for and charged on the profit realised by the company as the company qualifies as a small company
2.

Average number of employees

Average number of employees during the year was 0 (2024 : 0).
3.

Share Capital

Authorised
1,000 Class A shares of £1.00 each
Allotted, called up and fully paid
2025
£		   2024
£
1,000 Class A shares of £1.00 each 1,000    1,000 
1,000    1,000 

3